author-photo

Nichole C. Farneth

University of California, Davis

8

Papers

149

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (85)
B7-04: Detection of EGFR mutations in plasma by allele-specific real-time PCR in non-small cell lung cancer (NSCLC)

2007 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327)

2006 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (53)
Elevated osteopontin (OPN) plasma levels are highly prognostic in advanced non-small cell lung cancer (NSCLC): Analysis of SWOG S0003

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Proeasome inhibition with bortezomib (PS-341) in combination with docetaxel (Doc) in prostate cancer (CaP) cells and xenografts

2005 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)